A Cbo Study Issues In Designing A Prescription Drug Benefit For Medicare
Download A Cbo Study Issues In Designing A Prescription Drug Benefit For Medicare full books in PDF, epub, and Kindle. Read online free A Cbo Study Issues In Designing A Prescription Drug Benefit For Medicare ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : |
Publisher | : |
Total Pages | : 68 |
Release | : 2002 |
Genre | : |
ISBN | : |
One of lawmakers' highest health-related priorities is adding a prescription drug benefit to Medicare. Although that program gives older Americans broad insurance coverage for many health needs, it provides only limited coverage of drugs not dispensed during a hospital stay. That gap in coverage has become increasingly significant as prescription drugs have assumed greater importance in the treatment of disease and as spending for outpatient prescription drugs has soared. Designing a Medicare drug benefit is a complex task, however. The competing goals for such a benefit mean that policymakers must make trade-offs (such as between broad coverage or widespread enrollment and cost). They must consider many different design elements and how those elements might interact. And they must try to avoid various problems that arise in creating such a benefit. Ultimately, the choices that designers make will affect not only the cost of the benefit but a host of other factors, such as demand for and prices of prescription drugs, spending by other federal and state programs, and how various parts of the market for health insurance operate.
Author | : |
Publisher | : |
Total Pages | : 76 |
Release | : 2002 |
Genre | : Drugs |
ISBN | : |
Author | : United States. Congressional Budget Office |
Publisher | : |
Total Pages | : |
Release | : 2002* |
Genre | : |
ISBN | : |
Author | : Congressional Budget Congressional Budget Office |
Publisher | : CreateSpace |
Total Pages | : 68 |
Release | : 2014-11-15 |
Genre | : |
ISBN | : 9781503231214 |
One of lawmakers' highest health-related priorities is adding a prescription drug benefit to Medicare. Although that program gives older Americans broad insurance coverage for many health needs, it provides only limited coverage of drugs not dispensed during a hospital stay. That gap in coverage has become increasingly significant as prescription drugs have assumed greater importance in the treatment of disease and as spending for outpatient prescription drugs has soared. Designing a Medicare drug benefit is a complex task, however. The competing goals for such a benefit mean that policymakers must make trade-offs (such as between broad coverage or widespread enrollment and cost). They must consider many different design elements and how those elements might interact. And they must try to avoid various problems that arise in creating such a benefit. Ultimately, the choices that designers make will affect not only the cost of the benefit but a host of other factors, such as demand for and prices of prescription drugs, spending by other federal and state programs, and how various parts of the market for health insurance operate. The Congressional Budget Office (CBO) has had to wrestle with those issues in recent years to produce cost estimates of the various Medicare drug proposals debated in the Congress. This study summarizes the main design choices facing policymakers and explores the implications of those choices for cost and coverage. To illustrate the effect of those choices on cost, it also discusses CBO's cost estimates for four proposals that represent a broad array of designs for a Medicare drug benefit. For the sake of simplicity, this study focuses on a standalone drug benefit-one that would be a freestanding addition to Medicare rather than part of a broad effort to restructure the program. Broad reform proposals raise important policy issues but ones that are beyond the scope of this analysis.
Author | : |
Publisher | : |
Total Pages | : |
Release | : 2002 |
Genre | : |
ISBN | : |
Author | : Julie Ann Somers |
Publisher | : DIANE Publishing |
Total Pages | : 36 |
Release | : 2010 |
Genre | : Health & Fitness |
ISBN | : 1437940390 |
This is a print on demand edition of a hard to find publication. Contents:(1) Overview of the Medicare Prescription Drug Benefit Program: Design of the Medicare Prescription Drug Benefit; Distribution of Spending in Medicare Part D; The Role of Private Plans in Medicare Part D; (2) Generic Drugs in Medicare Part D: Generic Substitution; Therapeutic Substitution; Comparing Potential Savings from Generic and Therapeutic Substitution; (3) Implications of Future Developments: First-Time Generic Entry; New Brand-Name Drugs; Biologics. (4) Appendix: Description of Data Used in This Analysis. Charts and tables.
Author | : |
Publisher | : |
Total Pages | : 52 |
Release | : 2002 |
Genre | : Drugs |
ISBN | : |
Author | : Anna Cook |
Publisher | : |
Total Pages | : 48 |
Release | : 2014-09-03 |
Genre | : |
ISBN | : 9781457856631 |
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In FY 2013, Medicare Part D covered 39 million people. The federal government spent $59 billion net of premiums on Part D in that year; after accounting for certain payments from states under the program, the net federal cost was $50 billion, which represented 10% of net federal spending for Medicare. A combination of broader trends in the prescription drug market and lower-than-expected enrollment in Part D has contributed to much lower spending for the program than projected when the MMA became law in 2003. This report examines the federal budgetary cost and competitive design of Medicare Part D and compares Medicare Part D and Medicaid Fee for Service. Figures and tables. This is a print on demand report.
Author | : Joseph Antos |
Publisher | : |
Total Pages | : 0 |
Release | : 2002-11 |
Genre | : |
ISBN | : 9780756728564 |
Medicare offers broad insurance protection for many health needs of the nation's elderly & disabled residents, but it provides no coverage for the costs of most outpatient prescription drugs (PD). As spending for those PD has soared in recent years, adding a PD benefit to Medicare has become a top health issue for lawmakers. This study discusses an approach to estimating the costs of various designs for a Medicare PD benefit. Describes the broad choices available to policymakers, some problems raised by particular design choices, & the implications of those choices for the cost of four specific proposals, which together cover a wide spectrum of approaches for delivering a Medicare PD benefit. Charts & tables.
Author | : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health |
Publisher | : |
Total Pages | : 140 |
Release | : 2002 |
Genre | : Medical |
ISBN | : |